A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies

Journal of Viral Hepatitis

Volumn 24, Issue 5, 2017, Pages 404-411

  Bartlett, S R ^a   Wertheim, J O ^b   Bull, R A ^a   Matthews, G V ^a   Lamoury, F M J ^a   Scheffler, K ^b   Hellard, M ^c   Maher, L ^a   Dore, G J ^a   Lloyd, A R ^a   Applegate, T L ^a   Grebely, J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c BURNET INSTITUTE   (Australia)

Author keywords

hepatitis C virus; human immunodeficiency virus; modelling; molecular epidemiology; treatment as prevention

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; CHRONIC HEPATITIS C; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; INFORMATION PROCESSING; INFORMED CONSENT; MALE; PHYLOGENY; POPULATION RESEARCH; RISK FACTOR; SIMULATION; CLASSIFICATION; CLUSTER ANALYSIS; COMPLICATION; DNA SEQUENCE; GENETICS; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; TRANSMISSION; TREATMENT OUTCOME; YOUNG ADULT;

ANTIVIRUS AGENT;

ADULT; ANTIVIRAL AGENTS; AUSTRALIA; CLUSTER ANALYSIS; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85018742301     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12652     Document Type: Article

References (40)

1. Hellard M, Rolls D, Davis RS, et al. The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs. J Hepatol. 2013;58:S23–S24.
2. Anderson RM, Gupta S, Ng W. The significance of sexual partner contact networks for the transmission dynamics of HIV. J Acquir Immune Defic Syndr. 1990;3:417–429.
3. Robinson K, Cohen T, Colijn C. The dynamics of sexual contact networks: effects on disease spread and control. Theor Popul Biol. 2012;81:89–96.
4. Biernacki P, Waldorf D. Snowball sampling – problems and techniques of chain referral sampling. Sociol Method Res. 1981;10:141–163.
5. Kaplan EH, Heimer R. A model-based estimate of HIV infectivity via needle sharing. J Acquir Immune Defic Syndr. 1992;5:1116–1118.
6. Hudgens MG, Longini IM, Vanichseni S, et al. Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. Am J Epidemiol. 2002;155:159–168.
7. Henderson DK, Fahey BJ, Willy M, et al. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures a prospective evaluation. Ann Intern Med. 1990;113:740–746.
8. Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J. Estimating per-act HIV transmission risk: a systematic review. AIDS. 2014;28:1509–1519.
9. Moloughney BW. Transmission and postexposure management of bloodborne virus infections in the health care setting: where are we now? Can Med Assoc J. 2001;165:445–451.
10. Lewis F, Hughes GJ, Rambaut A, Pozniak A, Leigh Brown AJ. Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med. 2008;5:e50.
11. Mehta SR, Wertheim JO, Brouwer KC, et al. HIV transmission networks in the San Diego-Tijuana border region. EBioMedicine. 2015;2:1456–1463.
12. Little SJ, Kosakovsky Pond SL, Anderson CM, et al. Using HIV networks to inform real time prevention interventions. PLoS ONE. 2014;9:e98443.
13. Oster AM, Wertheim JO, Hernandez AL, Ocfemia MC, Saduvala N, Hall HI. Using molecular HIV surveillance data to understand transmission between subpopulations in the United States. J Acquir Immune Defic Syndr. 2015;70:444–451.
14. Wertheim JO, Oster AM, Hernandez AL, Saduvala N, Banez Ocfemia MC, Hall HI. The international dimension of the U.S. HIV transmission network and onward transmission of HIV recently imported into the United States. AIDS Res Hum Retroviruses. 2016;32:10–11.
15. Wertheim JO, Kosakovsky Pond SL, Little SJ, De Gruttola V. Using HIV transmission networks to investigate community effects in HIV prevention trials. PLoS ONE. 2011;6:e27775.
16. Poon AF, Gustafson R, Daly P, et al. Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study. Lancet HIV. 2016;3:e231–e238.
17. Bartlett SR, Jacka B, Bull RA, et al. HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection. Infect Genet Evol. 2016;37:252–258.
18. Sacks-Davis R, Daraganova G, Aitken C, et al. Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs. PLoS ONE. 2012;7:e47335.
19. Leventhal GE, Kouyos R, Stadler T, et al. Inferring epidemic contact structure from phylogenetic trees. PLoS Comput Biol. 2012;8:e1002413.
20. Villandre L, Stephens DA, Labbe A, et al. Assessment of overlap of phylogenetic transmission clusters and communities in simple sexual contact networks: applications to HIV-1. PLoS ONE. 2016;11:e0148459.
21. Rolls DA, Wang P, Jenkinson R, et al. Modelling a disease-relevant contact network of people who inject drugs. Soc Networks. 2013;35:699–710.
22. Rolls DA, Sacks-Davis R, Jenkinson R, et al. Hepatitis C transmission and treatment in contact networks of people who inject drugs. PLoS ONE. 2013;8:e78286.
23. Dore GJ, Hellard M, Matthews GV, et al. Effective treatment of injecting drug users with recently acquired hepatitis C virus infection. Gastroenterology. 2010;138:123–135 e1-2.
24. Teutsch S, Luciani F, Scheuer N, et al. Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Public Health. 2010;10:633.
25. White B, Dore GJ, Lloyd AR, Rawlinson WD, Maher L. Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study. Med J Australia. 2014;201:326–329.
26. Lamoury FM, Jacka B, Bartlett S, et al. The influence of hepatitis C virus genetic region on phylogenetic clustering analysis. PLoS ONE. 2015;10:e0131437.
27. Larkin MA, Blackshields G, Brown NP, et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007;23:2947–2948.
28. Wertheim JO, Brown AJL, Hepler NL, et al. The global transmission network of HIV-1. J Infect Dis. 2014;209:304–313.
29. Tamura K, Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial-DNA in humans and chimpanzees. Mol Biol Evol. 1993;10:512–526.
30. Wilson DB. Dimension of the loop-erased random walk in three dimensions. Phys Rev E Stat Nonlin Soft Matter Phys. 2010;82(6 Pt 1):062102.
31. Urbanus AT, van de Laar TJ, Stolte IG, et al. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS. 2009;23:F1–F7.
32. Aitken CK, McCaw RF, Bowden DS, et al. Molecular epidemiology of hepatitis C virus in a social network of injection drug users. J Infect Dis. 2004;190:1586–1595.
33. Matthews GV, Pham ST, Hellard M, et al. Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C. Clin Infect Dis. 2011;52:803–811.
34. Bradshaw D, Jacka B, Sacks-Davis R, et al. A novel method comparing sexual networks with the HCV phylogeny in HIV-positive MSM with acute HCV infection identifies two potential intervention targets for permucosally transmitted HCV in Australia. HIV Med. 2014;15:136.
35. Bretana NA, Boelen L, Bull R, et al. Transmission of hepatitis C virus among prisoners, Australia, 2005-2012. Emerg Infect Dis. 2015;21:765–774.
36. Jordan AE, Perlman DC, Neurer J, Smith DJ, Des Jarlais DC, Hagan H. Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: a systematic review and meta-analysis. Int J STD AIDS. 2016;pii:e0956462416630910.
37. Martin NK, Thornton A, Hickman M, et al. Can hepatitis C virus (HCV) direct-acting antiviral treatment as prevention reverse the HCV epidemic among men who have sex with men in the United Kingdom? Epidemiological and modeling insights. Clin Infect Dis. 2016;62:1072–1080.
38. Martin NK, Vickerman P, Grebely J, et al. Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals. Hepatology. 2013;58:1598–1609.
39. Martin NK, Vickerman P, Dore GJ, Hickman M. The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention. Curr Opin HIV AIDS. 2015;10:374–380.
40. The Kirby Institute. HIV, Viral Hepatitis and Sexually Transmissible Infections in Australia Annual Surveillance Report 2015. Sydney NSW: The Kirby Institute, UNSW Australia. 20522015.